ABOVE |
group with a D2B time > 60 min |
AFM |
atomic force microscope |
BELOW |
group with a D2B time ≤ 60 min |
BMI |
body mass index |
C3a |
complement factor C3a |
C5a |
complement factor C5a |
cGMP |
cyclic guanosine monophosphate |
CK |
creatine kinase |
CRP |
c-reactive protein |
CVRF |
cardiovascular risk-factor |
D2B |
door-to-balloon time |
ECLS |
extracorporeal life support |
ECMO |
extracorporeal membrane oxygenation |
eGC |
endothelial glycocalyx |
ELISA |
enzyme-linked immunosorbent assay |
ESC |
European Society of Cardiology |
FDC |
force distance curve |
HCl |
hydrochloric acid |
HIGH |
group with syndecan-1 levels ≤ 120 ng/mL |
HUVEC |
human umbilical vein endothelial cells |
I/R |
ischemia-reperfusion |
ICU |
intensive care unit |
IL |
interleukin |
IRI |
ischemia-reperfusion injury |
LDH |
lactate dehydrogenase |
LOW |
group with syndecan-1 levels ≤ 120 ng/mL |
LVEF |
left ventricular ejection fraction |
M |
mean |
MMP |
matrix metalloproteinases |
NO |
nitric oxide |
NOA-280i |
Nitric Oxide Analyzer-280i |
NOx |
nitric oxide products |
PCI |
percutaneous coronary intervention |
Pro-BNP II |
pro-brain natriuretic peptide II |
ROSC |
return of spontaneous circulation |
RR |
Riva-Rocci, blood pressure |
SD |
standard deviation |
STEMI |
ST-elevation myocardial infarction |
Syn-1 |
syndecan-1 |
TIMP |
tissue inhibitor of matrix metalloproteinases |
VSMC |
vascular smooth muscle cells |